DelphX Announces Grant of Stock Options
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved the issuance of 1,100,000 stock options to eligible participants under its stock option plan.
The granted options come with a two-year maturity period and can be exercised at a price of $0.20 per common share.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), un'azienda focalizzata sullo sviluppo di prodotti strutturati per il mercato obbligazionario, ha annunciato una nuova concessione di opzioni su azioni. Il Consiglio di Amministrazione ha approvato l'emissione di 1.100.000 opzioni su azioni per i partecipanti idonei nel suo piano di opzioni su azioni.
Le opzioni concesse hanno un periodo di scadenza di due anni e possono essere esercitate a un prezzo di $0,20 per azione ordinaria.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), una empresa centrada en el desarrollo de productos estructurados para el mercado de renta fija, ha anunciado una nueva concesión de opciones sobre acciones. La Junta Directiva ha aprobado la emisión de 1.100.000 opciones sobre acciones para participantes elegibles bajo su plan de opciones sobre acciones.
Las opciones concedidas tienen un período de madurez de dos años y se pueden ejercer a un precio de $0.20 por acción ordinaria.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF)는 고정 수익 시장을 위한 구조화된 제품 개발에 주력하는 회사로, 새로운 주식 옵션 부여를 발표했습니다. 이사회는 주식 옵션 계획에 따라 적격 참가자에게 1,100,000개의 주식 옵션을 발행하는 것을 승인했습니다.
부여된 옵션은 2년의 만기 기간을 가지며, 주당 $0.20의 가격으로 행사할 수 있습니다.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), une entreprise axée sur le développement de produits structurés pour le marché des revenus fixes, a annoncé une nouvelle attribution d'options d'achat d'actions. Le Conseil d'Administration a approuvé l'émission de 1.100.000 options d'achat d'actions pour les participants éligibles dans le cadre de son plan d'options d'achat d'actions.
Les options accordées ont une durée de deux ans et peuvent être exercées à un prix de 0,20 $ par action ordinaire.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), ein Unternehmen, das sich auf die Entwicklung von strukturierten Produkten für den Anleihenmarkt konzentriert, hat eine neue Gewährung von Aktienoptionen angekündigt. Der Vorstand hat die Ausgabe von 1.100.000 Aktienoptionen an berechtigte Teilnehmer im Rahmen seines Aktienoptionsplans genehmigt.
Die gewährten Optionen haben eine Zwei-Jahres-Laufzeit und können zu einem Preis von 0,20 $ pro Stammaktie ausgeübt werden.
- None.
- None.
Toronto, Ontario--(Newsfile Corp. - March 14, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 1,100,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244675
FAQ
How many stock options did DelphX (DPXCF) grant in March 2025?
What is the exercise price for DelphX's (DPXCF) March 2025 stock options?
When do the DelphX (DPXCF) March 2025 stock options expire?
What exchange is DelphX (DPXCF) listed on?
